DANIEL GRIFFITH ANDERSON

Business address
C/O Sigilon Therapeutics, Inc., 100 Binney Street, Suite 600, Cambridge, MA, 02142
Top holdings (ownership)
SGTX
Get insider transactions for this reporting owner
DANIEL GRIFFITH ANDERSON has filed 2 SEC EDGAR filings since 03 Dec 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 04 Jun 2021 02 Jun 2021 001-39746
3 Open Document Open Filing 3 03 Dec 2020 03 Dec 2020 001-39746